Unknown

Dataset Information

0

Podocyte RNA sequencing reveals Wnt- and ECM-associated genes as central in FSGS.


ABSTRACT: Loss of podocyte differentiation can cause nephrotic-range proteinuria and Focal and Segmental Glomerulosclerosis (FSGS). As specific therapy is still lacking, FSGS frequently progresses to end-stage renal disease. The exact molecular mechanisms of FSGS and gene expression changes in podocytes are complex and widely unknown as marker changes have mostly been assessed on the glomerular level. To gain a better insight, we isolated podocytes of miR-193a overexpressing mice, which suffer from FSGS due to suppression of the podocyte master regulator Wt1. We characterised the podocytic gene expression changes by RNAseq and identified many novel candidate genes not linked to FSGS so far. This included strong upregulation of the receptor tyrosine kinase EphA6 and a massive dysregulation of circadian genes including the loss of the transcriptional activator Arntl. By comparison with podocyte-specific changes in other FSGS models we found a shared dysregulation of genes associated with the Wnt signaling cascade, while classical podocyte-specific genes appeared widely unaltered. An overlap with gene expression screens from human FSGS patients revealed a strong enrichment in genes associated with extra-cellular matrix (ECM) and metabolism. Our data suggest that FSGS progression might frequently depend on pathways that are often overlooked when considering podocyte homeostasis.

SUBMITTER: Bukosza EN 

PROVIDER: S-EPMC7164636 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

Podocyte RNA sequencing reveals Wnt- and ECM-associated genes as central in FSGS.

Bukosza Eva Nora EN   Kratochwill Klaus K   Kornauth Christoph C   Schachner Helga H   Aufricht Christoph C   Gebeshuber Christoph A CA  

PloS one 20200417 4


Loss of podocyte differentiation can cause nephrotic-range proteinuria and Focal and Segmental Glomerulosclerosis (FSGS). As specific therapy is still lacking, FSGS frequently progresses to end-stage renal disease. The exact molecular mechanisms of FSGS and gene expression changes in podocytes are complex and widely unknown as marker changes have mostly been assessed on the glomerular level. To gain a better insight, we isolated podocytes of miR-193a overexpressing mice, which suffer from FSGS d  ...[more]

Similar Datasets

| S-EPMC7139641 | biostudies-literature
| S-EPMC4696566 | biostudies-literature
| S-EPMC5619973 | biostudies-literature
| S-EPMC10809747 | biostudies-literature
| S-EPMC4214535 | biostudies-literature
| S-EPMC6645621 | biostudies-literature
| S-EPMC3986119 | biostudies-literature
| S-EPMC4331255 | biostudies-literature
| S-EPMC6885352 | biostudies-literature
| S-EPMC8474709 | biostudies-literature